Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 122 (RN7SKP122) is classified as a pseudogene related to the functional 7SK small nuclear RNA gene (RN7SK). Pseudogenes are typically non-coding, do not produce functional gene products, and are not considered therapeutic targets. RN7SKP122 is not known to be involved in biological processes or human disease and does not encode a protein, participate in molecular pathways, serve as a drug target, or function as a biomarker[3]. It is mainly annotated as a genomic sequence resembling the functional RN7SK gene but lacking evidence for expression or function[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 122 (RN7SKP122).